AB Science
Paris, Ile-de-France, France · Biotechnology · 135 employees
AB Science S.A. is a biopharmaceutical company specializing in the research and development of innovative therapies for various diseases. The company is focused on providing solutions for serious medical conditions, primarily in oncology and neurodegenerative disorders. AB Science's lead program, AB8939, is aimed at treating acute myeloid leukemia (AML). With strong financial backing, the company
Funding history
- Funding Round — $2.8M — Oct 2025
Recent signals
- Oct 17, 2025: Raised $2.8M
See plans & pricing → Track AB Science’s funding, hiring, and signals — with verified contacts — on Fundz.